openPR Logo
Press release

Vaccine Storage Equipment Market to Hit US$ 2.03 Bn by 2032, Says Persistence Market Research

10-07-2025 06:45 AM CET | Health & Medicine

Press release from: Persistence Market Research

Vaccine Storage Equipment Market

Vaccine Storage Equipment Market

The global vaccine storage equipment market is experiencing significant growth and is poised to continue expanding at a robust pace. With a forecasted market size of USD 1,247.2 million in 2025, the market is expected to reach USD 2,036.5 million by 2032, registering a compound annual growth rate (CAGR) of 7.3% during this period. This surge in demand is largely driven by increasing immunization initiatives, growing vaccine production, and advances in cold chain logistics. Organizations such as UNICEF, Gavi, and WHO have been instrumental in accelerating vaccine distribution through investments in various cold storage equipment, thus expanding the market.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35239

Key Industry Highlights

Several pivotal trends define the current landscape of the vaccine storage equipment market. A critical factor contributing to market growth is the imposition of stringent regulations by governments and health organizations to ensure vaccines are stored at optimal temperatures, preventing spoilage. With the rise in the demand for vaccines worldwide, especially in rural and underserved regions, there is a growing focus on portable, solar-powered refrigeration units that can operate in areas with limited electricity access.

Another notable trend is the rise in investments in ice-lined refrigerators, which are expected to see significant demand. In terms of technological advancement, global market leaders, including Thermo Fisher Scientific, PHC Corporation, and Helmer Scientific, are pushing the envelope in innovation to improve vaccine storage capabilities, enhancing their competitive position within the market.

Market Dynamics
Drivers

The global emphasis on immunization programs is one of the primary drivers of the vaccine storage equipment market. With organizations like WHO and UNICEF expanding their efforts to immunize populations against preventable diseases, effective vaccine distribution becomes crucial. The increasing number of temperature-sensitive vaccines, including the COVID-19 mRNA vaccines, HPV, and pneumococcal vaccines, requires advanced storage solutions such as ultra-low temperature freezers and refrigerators.

The COVID-19 pandemic highlighted the importance of maintaining the efficacy of vaccines during distribution, leading to an increased need for specialized storage units capable of handling temperatures ranging from -70°C to -20°C. This demand was particularly evident with the global distribution of mRNA vaccines, spurring rapid investments in cold chain infrastructure and specialized storage equipment.

Restraints

While the market is growing, several challenges remain, particularly in rural and underserved regions. One major restraint is the lack of uniform infrastructure, which hinders the effective deployment of vaccine storage equipment. Power outages, poor road connectivity, and inadequate trained personnel in these areas often lead to cold chain disruptions, causing vaccine spoilage and wastage. Despite the investments in backup systems and cold chain solutions, these challenges continue to impede the market's growth in remote regions.

To mitigate these issues, organizations are exploring alternatives such as solar-powered refrigerators and mobile cold chain units. Public-private partnerships are also essential to addressing these infrastructural gaps and ensuring that vaccines reach the most vulnerable populations.

Opportunities

The integration of advanced technologies such as Mobile Logistics Management Information Systems (LMIS) presents significant opportunities in the vaccine storage equipment market. These systems provide real-time tracking of vaccine distribution, improving cold chain efficiency and reducing wastage. The use of Internet of Things (IoT) technology in vaccine storage solutions has the potential to revolutionize how vaccines are monitored and stored, especially in remote areas where traditional infrastructure is lacking.

Governments and international organizations are increasingly supporting these digital solutions, creating a favorable environment for the adoption of advanced technologies in vaccine storage. For instance, Indonesia's introduction of the SMILE e-LMIS system in 2024, designed to monitor vaccine distribution and storage, is a prime example of how digital innovations are reshaping the cold chain sector.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/vaccine-storage-equipment-market.asp

Category-Wise Analysis

Product Insights

The ice-lined refrigerators (ILRs) segment is expected to witness significant growth, with a projected CAGR of 8.5% during the forecast period. ILRs are the most widely used vaccine storage equipment, particularly in low-income countries with unstable power grids. These units can maintain a temperature range of 2°C to 8°C even during power outages, making them highly reliable and cost-effective for vaccine storage.

ILRs are increasingly favored by global health organizations like WHO and Gavi, which support their widespread adoption in rural and underserved regions. For example, in 2021, Blue Star Limited introduced a new range of ILRs designed to maintain a stable temperature for up to 48 hours without power, improving vaccine storage capacity in remote regions.

End-User Insights

Hospitals and clinics are the leading consumers of vaccine storage equipment, driven by the need to ensure the stability and efficacy of vaccines for national immunization programs. These institutions require large-scale storage units like ILRs, walk-in coolers, and deep freezers. Additionally, government health departments and international organizations such as UNICEF are increasingly involved in procuring vaccine storage equipment for healthcare centers, especially in emerging markets.

Regional Insights

North America

North America is expected to dominate the vaccine storage equipment market, accounting for 34.1% of the market share in 2025. The region's dominance is driven by the rapid adoption of advanced cold storage systems, including ultra-low temperature freezers and solar-powered refrigerators. Additionally, government initiatives are promoting the use of automated vaccine storage solutions to preserve vaccine efficacy.

In 2023, the U.S. Agency for International Development (USAID) donated solar-powered vaccine refrigerators to healthcare facilities in Guyana's remote regions, exemplifying the region's commitment to improving global vaccine storage capabilities.

Asia Pacific

Asia Pacific is experiencing significant growth in vaccine storage equipment adoption, driven by government-led initiatives like India's Electronic Vaccine Intelligence Network (eVIN). This system allows for real-time tracking of vaccine distribution, helping to reduce waste and improve logistics efficiency. The region is also investing in solar-powered refrigerators and IoT-enabled cold storage solutions to overcome logistical challenges, particularly in rural areas.

Indonesia's adoption of eVIN technology in 2018, under the SMILE initiative, demonstrates the region's growing focus on digital vaccine management solutions. Furthermore, countries like India are rolling out over 29,000 vaccine storage centers, improving vaccine access and storage capacity.

Europe

Europe is another key region in the vaccine storage equipment market, projected to grow at a CAGR of 6.7% by 2032. The European Union has been instrumental in providing vaccine storage solutions to developing nations, with several initiatives focused on strengthening cold chain logistics in regions at risk of vaccine-preventable diseases.

In 2024, the EU, in collaboration with UNICEF, donated essential vaccine storage equipment to Montenegro, including refrigerators and refrigerated vehicles, to support the country's vaccination efforts.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35239

Competitive Landscape

The global vaccine storage equipment market is highly competitive, with major players continually striving for innovation and technological advancement. Companies such as Thermo Fisher Scientific, PHC Corporation, Helmer Scientific, and B Medical Systems are investing in ultra-low temperature freezers, solar-powered refrigerators, and IoT-enabled storage solutions to meet the rising demand for effective vaccine preservation.

Key Industry Developments

In February 2025, B Medical Systems launched the Ultra-Low Freezer U201, the first WHO PQS prequalified ultra-low freezer. This 214L capacity unit can store vaccines at temperatures ranging from -86°C to -20°C, supporting mRNA vaccines and cell therapy in extreme climates.

Thermo Fisher Scientific introduced the TSX Series Ultra-Low Temperature Freezers in March 2024, designed to provide energy-efficient and sustainable vaccine storage solutions.

In 2025, WuXi Biologics sold its vaccine manufacturing facility in Ireland to Merck & Co. for $500 million, expanding Merck's vaccine production capabilities.

Future Outlook

The vaccine storage equipment market is expected to maintain its growth trajectory, driven by increasing demand for vaccines, advancements in cold chain technology, and government investments in healthcare infrastructure. The integration of digital technologies like IoT and LMIS will further enhance cold chain management, improving the efficiency of vaccine distribution worldwide.

As governments and global health organizations continue to prioritize immunization programs, the vaccine storage equipment market is poised to expand significantly, particularly in underserved regions that require reliable and cost-effective storage solutions. The future looks promising, with technological advancements and strategic partnerships creating a favorable environment for market growth.

Read More Related Reports:

Laboratory Flask Market https://www.persistencemarketresearch.com/market-research/laboratory-flask-market.asp
Fibromyalgia Treatment Market https://www.persistencemarketresearch.com/market-research/fibromyalgia-treatment-market.asp
Septoplasty Market https://www.persistencemarketresearch.com/market-research/septoplasty-market.asp
Injection Lipolysis Market https://www.persistencemarketresearch.com/market-research/injection-lipolysis-market.asp
Photon Counting Ct Market https://www.persistencemarketresearch.com/market-research/photon-counting-ct-market.asp

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccine Storage Equipment Market to Hit US$ 2.03 Bn by 2032, Says Persistence Market Research here

News-ID: 4210684 • Views:

More Releases from Persistence Market Research

Tire Shredder Market Driving Sustainability Through Advanced Recycling Technologies
Tire Shredder Market Driving Sustainability Through Advanced Recycling Technolog …
The tire shredder market is rapidly emerging as a crucial component of the global circular economy, enabling the transformation of waste tires into valuable materials. With millions of tires discarded annually across the world, the environmental impact of unmanaged rubber waste has become a significant concern. Tire shredders have risen as a sustainable solution-efficiently breaking down end-of-life tires into smaller fragments that can be reused for various industrial purposes such
VAV Diffusers Market Revolutionizing Airflow Control with Smart HVAC Solutions
VAV Diffusers Market Revolutionizing Airflow Control with Smart HVAC Solutions
The Variable Air Volume (VAV) Diffusers Market is transforming the way buildings manage airflow, comfort, and energy efficiency. As industries, commercial complexes, and smart buildings continue to prioritize indoor air quality and sustainability, VAV diffusers are emerging as essential components in modern HVAC systems. These diffusers automatically adjust air volume based on room conditions, eliminating the inefficiencies of constant air volume systems. By integrating intelligent control technologies, sensors, and automation,
Diamond Tools Market Redefining Cutting Technology Through Diamond Strength
Diamond Tools Market Redefining Cutting Technology Through Diamond Strength
The diamond tools market size is anticipated to reach a value of US$13.13 Bn in 2024. It is estimated to record a CAGR of 7.4% during the forecast period between 2024 and 2031. A considerable value of US$27.78 Bn is predicted to be exhibited by the market in 2031. Increasing construction activities in both developed and developing countries are projected to bolster demand by 2031. It is mainly attributed to
Therapeutic Drug Monitoring Market Growth to Accelerate at 8.9% CAGR through 2032 - Persistence Market Research
Therapeutic Drug Monitoring Market Growth to Accelerate at 8.9% CAGR through 203 …
The global Therapeutic Drug Monitoring (TDM) market, valued at USD 2.4 billion in 2025, is projected to experience robust growth, reaching USD 4.4 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 8.9%. This growth is driven by increasing chronic diseases, the growing need for personalized medicine, and the rising demand for optimized drug therapies. TDM is an essential component in monitoring patients receiving medications with narrow therapeutic

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion